Skip to main content

Table 5 Changes from baseline in SGRQ and SF-36 scores*

From: One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

  MF-DPI Placebo MF-DPI – Placebo
  n Mean n Mean Mean P value
SGRQ scores       
   Total 504 -3.92 241 -0.64 -3.28 0.003
   Activity 506 -4.20 242 -1.05 -3.15 0.021
   Impacts 516 -2.81 244 -0.25 -2.58 0.031
   Symptoms 534 -7.21 248 -2.26 -4.95 0.004
SF-36 PCS score 503 1.05 235 0.01 1.04 0.050
SF-36 MCS score 503 0.25 235 -0.32 0.57 0.372
  1. MCS = mental component summary; MF-DPI = mometasone furoate administered via a dry powder inhaler; PCS = physical component summary; SF-36 = 36-item short form; SGRQ = St. George's respiratory questionnaire.
  2. *This table shows results for subjects who completed HRQOL questionnaires at both baseline and endpoint.
  3. Pooled treatment groups.